carboxanilide, sodium salt) in cultured cells, but not from MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). Formazan generation from XTTis known to be stimulated by cytochrome c oxidase (COX) inhibitors such as KCNand NaN3, whereas MTTreduction is not affected by them. So, the effect of DSGon COXwas examined. DSGdid not directly inhibit the enzyme, but the cellular enzyme activity was decreased by exposure to DSG.It was thought that stimulation of XTTreduction by DSGresulted from the decrease of cellular cytochrome c oxidase activity.
DSG1}is a more active derivative of spergualin (SG), an antitumor antibiotic produced by a strain of Bacillus laterosporus2). DSGhas strong suppressive effects on both humoral and cell-mediated immune responses in animals3~5) and has been used in renal transplantation as a novel immunosuppressant, named gusperimus. In spite of its therapeutic effectiveness, the biochemical mechanism of action of DSGhas not been clearly understood. We had found in the assay of cytotoxicity of DSGand SGthat they gave inconsistent results depending on the type of tetrazoliums6) used for assay of cell growth. In this paper we describe that cellular XTT reducing activity is stimulated by DSGtreatment and is caused by the decrease of COX, the terminal enzyme in the mitochondrial respiratory chain.
Materials and Methods
Material s DSG, methyldeoxyspergualin, and N-30 were provided from Takara Shuzou Co., Ltd. and Nippon Kayaku Co., Ltd., respectively. SG and its analogs were prepared by us2>7). Fetal bovine and horse sera were purchased from ICN Cytochrome c Oxidase Activity COXwas measured by the spectrophotometric assay10), in which the rate of oxidation of ferrocytochrome c was traced by the decrease in the absorbancy of 550nm every 15 seconds. Ferrocytochrome c was prepared from cytochrome c dissolved in 0.01 m phosphate buffer, pH 7.0 by reduction with ascorbic acid, and dialyzed for the same buffer for 12 hours before the assay. The reaction was initiated by the addition of an enzymesolution to the reaction mixture (1 ml Relationship between Immunosuppression and Enhancement of XTTReduction in DSGDerivatives To knowwhether the enhancement of XTTreduction is related to immunosupressive activity of DSG,active analogs, inactive degradation products of SG (SG-A and SG-B), and polyamines as to immunosuppression were tested on XTTreducing activity.
As shown in Fig. 3, methyldeoxyspergualin and N-30 having immunosuppressive activity enhanced XTT reduction. SG-A and SG-B did not show the enhancement, while their cytotoxic activity was lost. Polyamines such as spermidine, putrescine, and spermine showed almost the same inhibition in MTTand XTTassays. The enhancement of XTT reduction is brought about only by immunosuppressive substances.
Discussion
DSGor SG treatment stimulated XTTreduction without any effect on MTTreduction. This result is similar to that obtained using COX inhibitors, NaN3 and KCNn). The effect on COXofDSG was examined. DSG did not directly inhibit COX,but cells preincubated by the drug showed decreased activity of COX.Fromstructure-activity rela- SEPT. 1999 L1210 cells treated by DSGfor 48h were determined for COX activity. The cell homogenates were prepared as described in Materials and Methods. Specific activity of COXwere expressed as A OD550/min/mg protein.
tionships, the enhancement of XTTreduction is brought about only by immunosuppressive substances. Previously we reported that DSGinhibited induction of inducible nitric oxide synthase by IFN-y and LPS in macrophage cell line, J774A.1 cells12). The structure-activity relationships is similar to the case of the decrease of COXactivity. The decrease of iNOS by DSG is easily understandable, because expression ofiNOS is activated by NF-*cB13). DSGbinds to HSc70 and HSP9014 15) and inhibits the translocation ofNFkB to nucleus from cytosol and antigen processing by inhibiting chaperoning activity ofHSc7016'17). Since COX is one of hemoproteins inhibited by NO18 19), it is difficult to explain how DSG reduces COXactivity. Studies on the mechanism of action of DSGwill clarify the regulation network of respiration by NOand COX.
There are several colorimetric assay methods which are based on the bioreduction of a variety of tetrazolium salts to intensely colored formazan. It is now evidenced that MTT reduction occurs extramitochondrially and involves NADH and NADH-dependent mechanisms that are insensitive to respiratory chain mhibitors20). Our result showed that XTT reduction involved the mitochondrial respiratory chain, unlike MTT.
During the preparation of this manuscript, it was reported by Odaka et al. that Only XTTreduction was enhanced by DSGtreatment. This apparent discrepancy maycome from the fact that they used Celltiter 96á" aqueous nonradioactive cell proliferation assay kit as the MTTassay. The manual for the kit states the method is based on the reduction of MTS (3 -(4,5 -dimethylthiazol-2-yl)-5-(3 carboxymethoxyphenyl)-2-(4-sulfophenyl)-2//-tetrazolium, inner salt) with PMS22). So we suppose that they observed the enhanced reduction of MTSby DSG instead of MTT. Since MTSis structurally related to XTT and also requires PMS as an electron coupler, the reduction of MTSmight involve COXwhich is inhibited by DSG, resulting in enhanced reduction as with the case ofXTT.
